Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Peperomia pellucida (L.) Kunth is a tropical medicinal herb used to manage inflammatory, gastrointestinal, and respiratory disorders [PMID:35153134], exhibiting antimicrobial, antidiabetic, and antioxidant activities [PMID:30562552, PMID:39403726].
Contexte
Peperomia pellucida (L.) Kunth is an annual weed in the Piperaceae family, primarily distributed in the Neotropics, Africa, Southeast Asia, and Australia, typically preferring humid environments with reduced solar radiation [PMID:30562552, PMID:40630672].
Usages traditionnels
It is popularly employed in the treatment of abscesses, abdominal pain, skin sores, conjunctivitis, measles, kidney troubles [PMID:30562552], headache, fever, and hypertension [PMID:34759740], and is used in Cameroonian traditional medicine for fracture healing [PMID:28372562].
Composés actifs
The plant contains polyphenols, tannins, flavonoids, saponins, alkaloids, and terpenoids [PMID:39403726]. Specific identified compounds include $\beta$-caryophyllene, carotol, dillapiole, ellagic acid, pellucidin A, phytol, vitexin [PMID:35153134], as well as 2,4,5-trimethoxycinnamic acid, 5,6,7-trimethoxyflavone, and sesamin [PMID:33828573].
Mécanisme d'action
Bioactive compounds may interact with proteins such as estrogen receptors, NOS, NF-$\kappa$B, PPAR-gamma, ACE, aldose reductase, alpha-glucosidase, alpha-amylase, DPP-IV, insulin receptor, and AChE [PMID:40630672]. In human retinal pigment epithelial cells, it suppresses glycation-induced inflammatory responses via the JAK-STAT3 signaling pathway [PMID:39037823] and modulates NF-$\kappa$B and PPAR-$\gamma$ signaling [PMID:39561439].
Preuves cliniques
Preuve DHypertension
Ethyl acetate fraction of ethanolic extract showed ACE-inhibitory activity and potential hypotensive effects in hypertensive rats [PMID:34759740].
Preuve DBone Fracture Healing
Aqueous and ethanolic extracts promoted fracture healing and bone regeneration in Wistar rats [PMID:28372562, PMID:23578859].
Preuve DArthritis
Methanol extract significantly reduced inflammation diameter in complete Freund's adjuvant-induced arthritis in rats [PMID:40156794].
Preuve DCardiotoxicity
Ethanolic extract exhibited cardioprotective effects against doxorubicin-induced myocardial injury in rats [PMID:39741574].
Preuve DPeriodontitis
Extract demonstrated anti-inflammatory efficacy in rats with induced periodontitis [PMID:39539670].
Preuve DCariogenic Bacteria
Essential oils displayed antibacterial activity against Streptococcus mutans, S. mitis, S. sanguinis, S. salivarius, S. sobrinus, Enterococcus faecalis, and Lactobacillus casei [PMID:36015120].
Sécurité et effets indésirables
The extract did not cause acute or chronic toxicity in mice [PMID:39403726]. An LD(50) of 5000 mg/kg indicates low toxicity [PMID:15120441]. Subchronic administration of aqueous extracts in mice showed no significant differences in serum transaminases, though some differences in micronucleus frequency were noted at 60 mg/kg freeze-dried extract [PMID:35544844].
Synthèse des preuves
The current evidence is primarily based on preclinical in vitro and in vivo animal studies (Level D) and literature reviews (Level C), with no human clinical trials provided.
Sources PubMed
1.PMID: 35153134 (2022) — Peperomia pellucida (L.) Kunth and eye diseases: A review on phytochemistry, pharmacology and toxicology. · Journal of integrative medicine
2.PMID: 30562552 (2019) — The chemistry and biological activities of Peperomia pellucida (Piperaceae): A critical review. · Journal of ethnopharmacology
3.PMID: 40630672 (2025) — Peperomia Pellucida (L.) Kunth: A Decade of Ethnopharmacological, Phytochemical, and Pharmacological Insights (2014-2025). · Journal of experimental pharmacology
4.PMID: 39403726 (2024) — Peperomia pellucida's Ingredients, Antioxidant Properties, and Safe Usage as Food and Herbal Medicine. · Journal of microbiology and biotechnology
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
— Gastroprotective activities of Peperomia pellucida L. and Pachyrhizus erosus L. extracts combination on ethanol-induced rats.
· Inflammopharmacology
6.PMID: 37950747 (2024) — Carotane sesquiterpenes from Peperomia pellucida and their anti-infective activities. · Natural product research
7.PMID: 39539670 (2024) — Anti-inflammatory effectiveness of Peperomia pellucida (L.) Kunth in rats induced with periodontitis. · Biochemistry and biophysics reports
8.PMID: 33828573 (2021) — Biosynthesis of Pellucidin A in Peperomia pellucida (L.) HBK. · Frontiers in plant science
9.PMID: 39741574 (2024) — Cardioprotective Effect of Peperomia pellucida against Doxorubicin-Induced Cardiotoxicity in Wistar Rats via Modulation of Electrocardiographic and Cardiac Biomarkers. · Journal of pharmacopuncture
10.PMID: 39037823 (2024) — Peperomia pellucida (L.) Kunth suppresses glycation-induced inflammatory response in human retinal pigment epithelial cell line ARPE-19 via JAK-STAT3 signaling. · Archiv der Pharmazie
11.PMID: 35335210 (2022) — Chemical Composition of Leaves, Stem, and Roots of Peperomia pellucida (L.) Kunth. · Molecules (Basel, Switzerland)
12.PMID: 16499324 (2006) — Bioactive compounds from Peperomia pellucida. · Journal of natural products
13.PMID: 34759740 (2021) — Peperomia pellucida (L.) Kunth as an angiotensin-converting enzyme inhibitor in two-kidney, one-clip Goldblatt hypertensive rats. · Saudi journal of biological sciences
14.PMID: 33280962 (2021) — Peperomia pellucida (L.) Kunth herbal tea: Effect of fermentation and drying methods on the consumer acceptance, antioxidant and anti-inflammatory activities. · Food chemistry
15.PMID: 27169181 (2016) — A Review of Traditional Medicinal Plants from Kachin State, Northern Myanmar. · Natural product communications
16.PMID: 28372562 (2017) — Aqueous extract of Peperomia pellucida (L.) HBK accelerates fracture healing in Wistar rats. · BMC complementary and alternative medicine
17.PMID: 35544844 (2022) — Hepatotoxicity and Mutagenicity assessment during chronic in vivo exposure to aqueous extracts from Peperomia pellucida. · Anais da Academia Brasileira de Ciencias
18.PMID: 35061852 (2022) — Variation in Peperomia pellucida growth and secondary metabolism after rhizobacteria inoculation. · PloS one
19.PMID: 36237510 (2022) — Stable and reproducible expression of bacterial ipt gene under the control of SAM-specific promoter (pKNOX1) with interference of developmental patterns in transgenic Peperomia pellucida plants. · Frontiers in plant science
20.PMID: 39561439 (2024) — In vitro anti-inflammatory activity and molecular docking of Peperomia pellucida (L.) Kunth extract via the NF-κB and PPAR-γ signalling in human retinal pigment epithelial cells. · Bioorganic chemistry
21.PMID: 40156794 (2024) — Anti-arthritis Activity of Methanol Extract of Peperomia pellucida in Complete Freund's Adjuvant Induced Arthritis in Wistar Rats. · Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria
22.PMID: 34642085 (2021) — Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. · Journal of integrative medicine
23.PMID: 33114252 (2020) — Isolation and Characterization of Phenylpropanoid and Lignan Compounds from Peperomia pellucida [L.] Kunth with Estrogenic Activities. · Molecules (Basel, Switzerland)
24.PMID: 33813721 (2021) — Obtainment of the spray-dried extracts of Peperomia pellucida L. (H.B.K.) using different atomization temperatures: physicochemical characterization and technological development for pharmaceutical applications. · Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
25.PMID: 41788793 (2026) — Formulation and in vitro evaluation of an anti-inflammatory herbal suppository containing Peperomia pellucida. · Frontiers in pharmacology
26.PMID: 23578859 (2013) — Ethanol extract of Peperomia pellucida (Piperaceae) promotes fracture healing by an anabolic effect on osteoblasts. · Journal of ethnopharmacology
27.PMID: 36015120 (2022) — Anticariogenic Activity of Three Essential Oils from Brazilian Piperaceae. · Pharmaceuticals (Basel, Switzerland)
28.PMID: 15120441 (2004) — Anti-inflammatory and analgesic activity of Peperomia pellucida (L.) HBK (Piperaceae). · Journal of ethnopharmacology